Proteomic Applications in Antimicrobial Resistance and Clinical Microbiology Studies

References

• Branden CI, Tooze J. Introduction to Protein Structure. Garland Science; 2012.
   Google Scholar
• Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537(7620):347. doi:10.1038/nature1994927629641
   PubMed Web of Science ®Google Scholar
• Jung RH, Kim M, Bhatt B, Choi JM, Roh JH. Identification of pathogenic bacteria from public libraries via proteomics analysis. Int J Environ Res Public Health. 2019;16(6):912. doi:10.3390/ijerph16060912
   Web of Science ®Google Scholar
• Han MJ, Lee JW, Lee SY. Understanding and engineering of microbial cells based on proteomics and its conjunction with other omics studies. Proteomics. 2011;11(4):721–743. doi:10.1002/pmic.20100041121229587
   PubMed Web of Science ®Google Scholar
• He F, Wu F, Zhong F, He F. Microbial proteomics: approaches, advances, and applications. J Bioinfo Proteom Imag Anal. 2016;2(1).
   Google Scholar
• Lum KK, Cristea IM. Proteomic approaches to uncovering virus–host protein interactions during the progression of viral infection. Expert Rev Proteomics. 2016;13(3):325–340. doi:10.1586/14789450.2016.114735326817613
   PubMed Web of Science ®Google Scholar
• Lee C-R, Lee JH, Park KS, Jeong BC, Lee SH. Quantitative proteomic view associated with resistance to clinically important antibiotics in Gram-positive bacteria: a systematic review. Front Microbiol. 2015;6:828. doi:10.3389/fmicb.2015.0082826322035
   PubMed Web of Science ®Google Scholar
• Stekhoven DJ, Omasits U, Quebatte M, Dehio C, Ahrens CH. Proteome-wide identification of predominant subcellular protein localizations in a bacterial model organism. J Proteomics. 2014;99:123–137. doi:10.1016/j.jprot.2014.01.01524486812
   PubMed Web of Science ®Google Scholar
• Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLoS Pathog. 2013;9(7):e1003467. doi:10.1371/journal.ppat.100346723853589
   PubMed Web of Science ®Google Scholar
• Beceiro A, Tomás M, Bou G. Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev. 2013;26(2):185–230.23554414
   PubMed Web of Science ®Google Scholar
• Yang Y, Hu M, Yu K, Zeng X, Liu X. Mass spectrometry-based proteomic approaches to study pathogenic bacteria-host interactions. Protein Cell. 2015;6(4):265–274. doi:10.1007/s13238-015-0136-625722051
   PubMed Web of Science ®Google Scholar
• Sampson SL. Mycobacterial PE/PPE proteins at the host-pathogen interface. Clin Dev Immunol. 2011;2011:1–11. doi:10.1155/2011/497203
   Google Scholar
• Senthilkumar B, Senbagam D, Prahalathan C, Anbarasu K. Gateways of pathogenic bacterial entry into host cells—salmonella In: Garrigues P, editor. Pocket Guide to Bacterial Infections. CRC Press; 2019:59–78.
   Google Scholar
• Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW. The genetics and pathology of mitochondrial disease. J Pathol. 2017;241(2):236–250. doi:10.1002/path.480927659608
   PubMed Web of Science ®Google Scholar
• Hartlova A, Krocova Z, Cerveny L, Stulik J. A proteomic view of the host–pathogen interaction: the host perspective. Proteomics. 2011;11(15):3212–3220. doi:10.1002/pmic.20100076721726044
   PubMed Web of Science ®Google Scholar
• Nicod C, Banaei-Esfahani A, Collins BC. Elucidation of host–pathogen protein–protein interactions to uncover mechanisms of host cell rewiring. Curr Opin Microbiol. 2017;39:7–15. doi:10.1016/j.mib.2017.07.00528806587
   PubMed Web of Science ®Google Scholar
• Ravinder K. Gill RK, Hecht GA. Host-Pathogen Interactions in Pathophysiology of Diarrheal DisordersIn: Said HM, editor. Physiology of the Gastrointestinal Tract (Sixth Edition). Academic Press; 2018:1547–1577.
   Google Scholar
• Inal JM, Ansa-Addo EA, Lange S. Interplay of Host–Pathogen Microvesicles and Their Role in Infectious Disease. Portland Press Limited; 2013.
   Google Scholar
• Solanki V, Tiwari M, Tiwari V. Host-bacteria interaction and adhesin study for development of therapeutics. Int J Biol Macromol. 2018;112:54–64. doi:10.1016/j.ijbiomac.2018.01.15129414732
   PubMed Web of Science ®Google Scholar
• Beltran PMJ, Federspiel JD, Sheng X, Cristea IM. Proteomics and integrative omic approaches for understanding host–pathogen interactions and infectious diseases. Mol Syst Biol. 2017;13(3).
   Web of Science ®Google Scholar
• Cook HV, Jensen LJ. An integrative approach to virus–host protein–protein interactions Methods Mol Biol. 2018;1819:175–196.30421404
   PubMedGoogle Scholar
• Van Els CA, Corbière V, Smits K, et al. Toward understanding the essence of post-translational modifications for the mycobacterium tuberculosis immunoproteome. Front Immunol. 2014;5:361. doi:10.3389/fimmu.2014.0036125157249
   PubMed Web of Science ®Google Scholar
• Du C, van Wezel GP. Mining for microbial gems: integrating proteomics in the postgenomic natural product discovery pipeline. Proteomics. 2018;18(18):1700332. doi:10.1002/pmic.201700332
   PubMed Web of Science ®Google Scholar
• Patel H, Whitehouse DB. 4 Microbial Proteomics In: Rapley R, editor. Genomics and Clinical Diagnostics. 2019:103.
   Google Scholar
• Blundon M, Ganesan V, Redler B, Van PT, Minden JS. Two–dimensional differencegel electrophoresis Methods Mol Biol. 2019;1855:229–247.30426421
   PubMedGoogle Scholar
• Magdeldin S, Enany S, Yoshida Y, et al. Basics and recent advances of two dimensional-polyacrylamide gel electrophoresis. Clin Proteomics. 2014;11(1):16. doi:10.1186/1559-0275-11-1624735559
   PubMed Web of Science ®Google Scholar
• Drabik A, Bodzoń-Kułakowska A, Silberring J. Gel electrophoresis In: Silberring PC, editor. Proteomic Profiling and Analytical Chemistry. Elsevier; 2016:115–143.
   Google Scholar
• May C, Brosseron F, Chartowski P, Meyer HE, Marcus K. Differential proteome analysis using 2D-DIGE Methods Mol Biol. 2012;893:75–82.22665295
   PubMedGoogle Scholar
• Novotny MV, Alley WR, Mann BF. Analytical glycobiology at high sensitivity: current approaches and directions. Glycoconj J. 2013;30(2):89–117. doi:10.1007/s10719-012-9444-822945852
   PubMed Web of Science ®Google Scholar
• Venne AS, Kollipara L, Zahedi RP. The next level of complexity: crosstalk of posttranslational modifications. Proteomics. 2014;14(4–5):513–524. doi:10.1002/pmic.20130034424339426
   PubMed Web of Science ®Google Scholar
• Di Venere M, Viglio S, Sassera D, et al. Do the complementarities of electrokinetic and chromatographic procedures represent the “Swiss knife” in proteomic investigation? An overview of the literature in the past decade. Electrophoresis. 2017;38(12):1538–1550. doi:10.1002/elps.20160050428130906
   PubMed Web of Science ®Google Scholar
• Johnson N, Březinová J, Stephens E, et al. Quantitative proteomics screen identifies a substrate repertoire of rhomboid protease RHBDL2 in human cells and implicates it in epithelial homeostasis. Sci Rep. 2017;7(1):7283. doi:10.1038/s41598-017-07556-328779096
   PubMed Web of Science ®Google Scholar
• Bespyatykh J, Smolyakov A, Guliaev A, et al. Proteogenomic analysis of Mycobacterium tuberculosis Beijing B0/W148 cluster strains. J Proteomics. 2019;192:18–26. doi:10.1016/j.jprot.2018.07.00230009986
   PubMed Web of Science ®Google Scholar
• Huang EL, Lefsrud MG. Temporal analysis of xylose fermentation by Scheffersomyces stipitis using shotgun proteomics. J Ind Microbiol Biotechnol. 2012;39(10):1507–1514. doi:10.1007/s10295-012-1147-422638791
   PubMed Web of Science ®Google Scholar
• Liu X, Hu Y, Pai P-J, Chen D, Lam H. Label-free quantitative proteomics analysis of antibiotic response in Staphylococcus aureus to oxacillin. J Proteome Res. 2014;13(3):1223–1233. doi:10.1021/pr400669d24156611
   PubMed Web of Science ®Google Scholar
• Kamaladevi A, Balamurugan K. Global proteomics revealed Klebsiella pneumoniae induced autophagy and oxidative stress in caenorhabditis elegans by inhibiting PI3K/AKT/mTOR pathway during infection. Front Cell Infect Microbiol. 2017;7:393. doi:10.3389/fcimb.2017.0039328932706
   PubMed Web of Science ®Google Scholar
• Dayon L, Sanchez J-C. Relative protein quantification by MS/MS using the tandem mass tag technology Methods Mol Biol. 2012;893:115–127.22665298
   PubMedGoogle Scholar
• Han J, Yi S, Zhao X, et al. Improved SILAC method for double labeling of bacterial proteome. J Proteomics. 2019;194:89–98. doi:10.1016/j.jprot.2018.12.01130553074
   PubMed Web of Science ®Google Scholar
• Wang B, Hom G, Zhou S, et al. The oxidized thiol proteome in aging and cataractous mouse and human lens revealed by ICAT labeling. Aging Cell. 2017;16(2):244–261.28177569
   PubMed Web of Science ®Google Scholar
• Rauniyar N, Yates III JR. Isobaric labeling-based relative quantification in shotgun proteomics. J Proteome Res. 2014;13(12):5293–5309. doi:10.1021/pr500880b25337643
   PubMed Web of Science ®Google Scholar
• Lottspeich F, Kellermann J. ICPL labeling strategies for proteome research Methods Mol Biol. 2011;753:55–64.21604115
   PubMedGoogle Scholar
• Chahrour O, Cobice D, Malone J. Stable isotope labelling methods in mass spectrometry-based quantitative proteomics. J Pharm Biomed Anal. 2015;113:2–20. doi:10.1016/j.jpba.2015.04.01325956803
   PubMed Web of Science ®Google Scholar
• Xu J, Wang H, Kong D 2-DE Compared with iTRAQ-based proteomic analysis of the functional regulation of proteins in Rhodococcus sp. BAP-1 response to fluoranthene. Paper presented at: IOP Conference Series: Earth and Environmental Science; 2018;111:012032.
   Google Scholar
• Syahir A, Usui K, Tomizaki K-Y, Kajikawa K, Mihara H. Label and label-free detection techniques for protein microarrays. Microarrays. 2015;4(2):228–244. doi:10.3390/microarrays402022827600222
   PubMedGoogle Scholar
• Krizman DB, Hembrough T, Thyparambil S, Liao W-L. SRM/MRM Assay for the GTPase KRas Protein (Kras). Google Patents; 2017.
   Google Scholar
• Zahedi Bialvaei A, Rahbar M, Yousefi M, Asgharzadeh M, Samadi Kafil H. Linezolid: a promising option in the treatment of Gram-positives. J Antimicrob Chemother. 2017;72(2):354–364. doi:10.1093/jac/dkw45027999068
   PubMed Web of Science ®Google Scholar
• Bonar E, Wójcik I, Wladyka B. Proteomics in studies of Staphylococcus aureus virulence. Acta Biochim Pol. 2015;62(3):367–381. doi:10.18388/abp.2015_108326307769
   PubMed Web of Science ®Google Scholar
• Neilson KA, Ali NA, Muralidharan S, et al. Less label, more free: approaches in label free quantitative mass spectrometry. Proteomics. 2011;11(4):535–553. doi:10.1002/pmic.20100055321243637
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wen Z, Washburn MP, Florens L. Improving label-free quantitative proteomics strategies by distributing shared peptides and stabilizing variance. Anal Chem. 2015;87(9):4749–4756. doi:10.1021/ac504740p25839423
   PubMed Web of Science ®Google Scholar
• Greco V, Piras C, Pieroni L, et al. Applications of MALDI-TOF mass spectrometry in clinical proteomics. Expert Rev Proteomics. 2018;15(8):683–696. doi:10.1080/14789450.2018.150551030058389
   PubMed Web of Science ®Google Scholar
• Schlichtemeier SM, Nahm CB, Xue A, Gill AJ, Smith RC, Hugh TJ. SELDI-TOF MS analysis of hepatocellular carcinoma in an Australian cohort. J Surg Res. 2019;238:127–136. doi:10.1016/j.jss.2019.01.00830771682
   PubMed Web of Science ®Google Scholar
• Anand S, Samuel M, Ang C-S, Keerthikumar S, Mathivanan S. Label-Based and Label-free strategies for protein quantitation Methods Mol Biol. 2017;1549:31–43.27975282
   PubMedGoogle Scholar
• Bereman MS. Tools for monitoring system suitability in LC MS/MS centric proteomic experiments. Proteomics. 2015;15(5–6):891–902. doi:10.1002/pmic.20140037325327420
   PubMed Web of Science ®Google Scholar
• Alreshidi MM, Dunstan RH, Macdonald MM, Smith ND, Gottfries J, Roberts TK. Metabolomic and proteomic responses of Staphylococcus aureus to prolonged cold stress. J Proteomics. 2015;121:44–55. doi:10.1016/j.jprot.2015.03.01025782752
   PubMed Web of Science ®Google Scholar
• Tsou -C-C, Tsai C-F, Tsui Y-H, et al. IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics. 2010;9(1):131–144. doi:10.1074/mcp.M900177-MCP20019752006
   PubMed Web of Science ®Google Scholar
• Kind T, Tsugawa H, Cajka T, et al. Identification of small molecules using accurate mass MS/MS search. Mass Spectrom Rev. 2018;37(4):513–532. doi:10.1002/mas.2153528436590
   PubMed Web of Science ®Google Scholar
• Paul D, Kumar A, Gajbhiye A, Santra MK, Srikanth R. Mass spectrometry-based proteomics in molecular diagnostics: discovery of cancer biomarkers using tissue culture. Biomed Res Int. 2013;2013:1–16. doi:10.1155/2013/783131
   Web of Science ®Google Scholar
• Matsumoto M, Matsuzaki F, Oshikawa K, et al. A large-scale targeted proteomics assay resource based on an in vitro human proteome. Nat Methods. 2017;14(3):251. doi:10.1038/nmeth.411628267743
   PubMed Web of Science ®Google Scholar
• Lee M-Y, Huang C-H, Kuo C-J, Lin C-LS, Lai W-T, Chiou S-H. Clinical proteomics identifies urinary CD14 as a potential biomarker for diagnosis of stable coronary artery disease. PLoS One. 2015;10(2):e0117169. doi:10.1371/journal.pone.011716925668619
   PubMed Web of Science ®Google Scholar
• Greco TM, Cristea IM. Proteomics tracing the footsteps of infectious disease. Mol Cell Proteomics. 2017;16(4 suppl 1):S5–S14. doi:10.1074/mcp.O116.06600128163258
   PubMed Web of Science ®Google Scholar
• Ayres JS. Cooperative microbial tolerance behaviors in host-microbiota mutualism. Cell. 2016;165(6):1323–1331. doi:10.1016/j.cell.2016.05.04927259146
   PubMed Web of Science ®Google Scholar
• Goodman AG, Rasmussen AL. Host-pathogen interactions during arboviral infections. Front Cell Infect Microbiol. 2019;9:77. doi:10.3389/fcimb.2019.0007730972308
   PubMed Web of Science ®Google Scholar
• Federspiel JD, Cristea IM. Considerations for identifying endogenous protein complexes from tissue via immunoaffinity purification and quantitative mass Spectrometry Methods Mol Biol. 2019;1977:115–143.30980326
   PubMedGoogle Scholar
• Vinayagam A, Gibson TE, Lee H-J, et al. Controllability analysis of the directed human protein interaction network identifies disease genes and drug targets. Proc Natl Acad Sci. 2016;113(18):4976–4981. doi:10.1073/pnas.160399211327091990
   PubMed Web of Science ®Google Scholar
• Auweter SD, Bhavsar AP, de Hoog CL, et al. Quantitative mass spectrometry catalogues Salmonella pathogenicity island-2 effectors and identifies their cognate host binding partners. J Biol Chem. 2011;286(27):24023–24035. doi:10.1074/jbc.M111.22460021566117
   PubMed Web of Science ®Google Scholar
• Joshi P, Greco TM, Guise AJ, et al. The functional interactome landscape of the human histone deacetylase family. Mol Syst Biol. 2013;9(1). doi:10.1038/msb.2013.26
   Web of Science ®Google Scholar
• Fels U, Gevaert K, Van Damme P. Proteogenomics in aid of host–pathogen interaction studies: a bacterial perspective. Proteomes. 2017;5(4):26. doi:10.3390/proteomes5040026
   Google Scholar
• Armean IM, Lilley KS, Trotter MW. Popular computational methods to assess multiprotein complexes derived from label-free affinity purification and mass spectrometry (AP-MS) experiments. Mol Cell Proteomics. 2013;12(1):1–13. doi:10.1074/mcp.R112.01955423071097
   PubMed Web of Science ®Google Scholar
• Choi H, Larsen B, Lin Z-Y, et al. SAINT: probabilistic scoring of affinity purification–mass spectrometry data. Nat Methods. 2011;8(1):70. doi:10.1038/nmeth.154121131968
   PubMed Web of Science ®Google Scholar
• Mellacheruvu D, Wright Z, Couzens AL, et al. The CRAPome: a contaminant repository for affinity purification–mass spectrometry data. Nat Methods. 2013;10(8):730. doi:10.1038/nmeth.255723921808
   PubMed Web of Science ®Google Scholar
• Ashford P, Hernandez A, Greco TM, et al. HVint: a strategy for identifying novel protein-protein interactions in herpes simplex virus type 1. Mol Cell Proteomics. 2016;15(9):2939–2953. doi:10.1074/mcp.M116.05855227384951
   PubMed Web of Science ®Google Scholar
• Miteva YV, Budayeva HG, Cristea IM. Proteomics-based methods for discovery, quantification, and validation of protein–protein interactions. Anal Chem. 2013;85(2):749–768. doi:10.1021/ac303325723157382
   PubMed Web of Science ®Google Scholar
• Toby TK, Fornelli L, Kelleher NL. Progress in top-down proteomics and the analysis of proteoforms. Annu Rev Anal Chem. 2016;9:499–519. doi:10.1146/annurev-anchem-071015-041550
   PubMed Web of Science ®Google Scholar
• Konijnenberg A, Bannwarth L, Yilmaz D, Koçer A, Venien Bryan C, Sobott F. Top down mass spectrometry of intact membrane protein complexes reveals oligomeric state and sequence information in a single experiment. Protein Sci. 2015;24(8):1292–1300. doi:10.1002/pro.270325970171
   PubMed Web of Science ®Google Scholar
• Shoemaker GK, van Duijn E, Crawford SE, et al. Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics. 2010;9(8):1742–1751.20418222
   PubMed Web of Science ®Google Scholar
• Uetrecht C, Barbu IM, Shoemaker GK, Van Duijn E, Heck AJ. Interrogating viral capsid assembly with ion mobility–mass spectrometry. Nat Chem. 2011;3(2):126. doi:10.1038/nchem.94721258385
   PubMed Web of Science ®Google Scholar
• Calderwood MA, Venkatesan K, Xing L, et al. Epstein–Barr virus and virus human protein interaction maps. Proc Natl Acad Sci. 2007;104(18):7606–7611. doi:10.1073/pnas.070233210417446270
   PubMed Web of Science ®Google Scholar
• Blasche S, Arens S, Ceol A, et al. The EHEC-host interactome reveals novel targets for the translocated intimin receptor. Sci Rep. 2014;4:7531. doi:10.1038/srep0753125519916
   PubMed Web of Science ®Google Scholar
• Ciferri C, Chandramouli S, Leitner A, et al. Antigenic characterization of the HCMV gH/gL/gO and pentamer cell entry complexes reveals binding sites for potently neutralizing human antibodies. PLoS Pathog. 2015;11(10):e1005230. doi:10.1371/journal.ppat.100523026485028
   PubMed Web of Science ®Google Scholar
• Leitner A, Faini M, Stengel F, Aebersold R. Crosslinking and mass spectrometry: an integrated technology to understand the structure and function of molecular machines. Trends Biochem Sci. 2016;41(1):20–32. doi:10.1016/j.tibs.2015.10.00826654279
   PubMed Web of Science ®Google Scholar
• Schweppe DK, Harding C, Chavez JD, et al. Host-microbe protein interactions during bacterial infection. Chem Biol. 2015;22(11):1521–1530. doi:10.1016/j.chembiol.2015.09.01526548613
   PubMedGoogle Scholar
• Tandon R, Mocarski ES. Viral and host control of cytomegalovirus maturation. Trends Microbiol. 2012;20(8):392–401. doi:10.1016/j.tim.2012.04.00822633075
   PubMed Web of Science ®Google Scholar
• Janssens S, Pulendran B, Lambrecht BN. Emerging functions of the unfolded protein response in immunity. Nat Immunol. 2014;15(10):910. doi:10.1038/ni.299125232821
   PubMed Web of Science ®Google Scholar
• Weekes MP, Tomasec P, Huttlin EL, et al. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell. 2014;157(6):1460–1472. doi:10.1016/j.cell.2014.04.02824906157
   PubMed Web of Science ®Google Scholar
• Fraisier C, Koraka P, Belghazi M, et al. Kinetic analysis of mouse brain proteome alterations following Chikungunya virus infection before and after appearance of clinical symptoms. PLoS One. 2014;9(3):e91397. doi:10.1371/journal.pone.009139724618821
   PubMed Web of Science ®Google Scholar
• Lopez V, Villar M, Queiros J, et al. Comparative proteomics identifies host immune system proteins affected by infection with Mycobacterium bovis. PLoS Negl Trop Dis. 2016;10(3):e0004541. doi:10.1371/journal.pntd.000454127027307
   PubMed Web of Science ®Google Scholar
• Abere B, Wikan N, Ubol S, et al. Proteomic analysis of chikungunya virus infected microgial cells. PLoS One. 2012;7(4):e34800. doi:10.1371/journal.pone.003480022514668
   PubMed Web of Science ®Google Scholar
• Beltran PMJ, Mathias RA, Cristea IM. A portrait of the human organelle proteome in space and time during cytomegalovirus infection. Cell Syst. 2016;3(4):361–373 e366. doi:10.1016/j.cels.2016.08.01227641956
   PubMed Web of Science ®Google Scholar
• Grabowski JM, Perera R, Roumani AM, et al. Changes in the proteome of Langat-infected Ixodes scapularis ISE6 cells: metabolic pathways associated with flavivirus infection. PLoS Negl Trop Dis. 2016;10(2):e0004180. doi:10.1371/journal.pntd.000418026859745
   PubMed Web of Science ®Google Scholar
• Diamond DL, Syder AJ, Jacobs JM, et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010;6(1):e1000719.20062526
   PubMed Web of Science ®Google Scholar
• PFo S, McCorrister S, Hu P, et al. Highly pathogenic H5N1 and novel H7N9 influenza A viruses induce more profound proteomic host responses than seasonal and pandemic H1N1 strains. J Proteome Res. 2015;14(11):4511–4523. doi:10.1021/acs.jproteome.5b0019626381135
   PubMed Web of Science ®Google Scholar
• Ding X, Lu J, Yu R, et al. Preliminary proteomic analysis of A549 cells infected with avian influenza virus H7N9 and influenza A virus H1N1. PLoS One. 2016;11(5):e0156017. doi:10.1371/journal.pone.015601727223893
   PubMed Web of Science ®Google Scholar
• Wood JJ, Boyne JR, Paulus C, et al. ARID3B: a novel regulator of the Kaposi’s sarcoma-associated herpesvirus lytic cycle. J Virol. 2016;90(20):9543–9555. doi:10.1128/JVI.03262-1527512077
   PubMed Web of Science ®Google Scholar
• Shen S, Li J, Hilchey S, et al. Ion-current-based temporal proteomic profiling of influenza-a-virus-infected mouse lungs revealed underlying mechanisms of altered integrity of the lung microvascular barrier. J Proteome Res. 2016;15(2):540–553. doi:10.1021/acs.jproteome.5b0092726650791
   PubMed Web of Science ®Google Scholar
• Vogels MW, van Balkom BW, Heck AJ, et al. Quantitative proteomic identification of host factors involved in the Salmonella typhimurium infection cycle. Proteomics. 2011;11(23):4477–4491. doi:10.1002/pmic.20110022421919203
   PubMed Web of Science ®Google Scholar
• Kaloyanova D, Vogels M, van Balkom BW, Helms JB. Quantitative proteomic identification of host factors involved in the Salmonella typhimurium infection cycle Methods Mol Biol. 2015;1225:29–45.25253246
   PubMedGoogle Scholar
• Villeneuve LM, Purnell PR, Stauch KL, Callen SE, Buch SJ, Fox HS. HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. J Neurovirol. 2016;22(5):564–574. doi:10.1007/s13365-016-0424-926843384
   PubMed Web of Science ®Google Scholar
• Wu X, Wang H, Bai L, et al. Mitochondrial proteomic analysis of human host cells infected with H3N2 swine influenza virus. J Proteomics. 2013;91:136–150. doi:10.1016/j.jprot.2013.06.03723856606
   PubMed Web of Science ®Google Scholar
• Gudleski-O’Regan N, Greco TM, Cristea IM, Shenk T. Increased expression of LDL receptor-related protein 1 during human cytomegalovirus infection reduces virion cholesterol and infectivity. Cell Host Microbe. 2012;12(1):86–96. doi:10.1016/j.chom.2012.05.01222817990
   PubMed Web of Science ®Google Scholar
• Hsu J-L, van den Boomen DJ, Tomasec P, et al. Plasma membrane profiling defines an expanded class of cell surface proteins selectively targeted for degradation by HCMV US2 in cooperation with UL141. PLoS Pathog. 2015;11(4):e1004811. doi:10.1371/journal.ppat.100481125875600
   PubMed Web of Science ®Google Scholar
• Matheson NJ, Sumner J, Wals K, et al. Cell surface proteomic map of HIV infection reveals antagonism of amino acid metabolism by Vpu and Nef. Cell Host Microbe. 2015;18(4):409–423. doi:10.1016/j.chom.2015.09.00326439863
   PubMed Web of Science ®Google Scholar
• Karniely S, Weekes MP, Antrobus R, et al. Human cytomegalovirus infection upregulates the mitochondrial transcription and translation machineries. MBio. 2016;7(2):e00029–00016. doi:10.1128/mBio.00029-1627025248
   PubMed Web of Science ®Google Scholar
• Itzhak DN, Tyanova S, Cox J, Borner GH. Global, quantitative and dynamic mapping of protein subcellular localization. Elife. 2016;5:e16950. doi:10.7554/eLife.1695027278775
   PubMed Web of Science ®Google Scholar
• Ribet D, Cossart P. Pathogen-mediated posttranslational modifications: a re-emerging field. Cell. 2010;143(5):694–702. doi:10.1016/j.cell.2010.11.01921111231
   PubMed Web of Science ®Google Scholar
• Liao G, Xie L, Li X, Cheng Z, Xie J. Unexpected extensive lysine acetylation in the trump-card antibiotic producer Streptomyces roseosporus revealed by proteome-wide profiling. J Proteomics. 2014;106:260–269. doi:10.1016/j.jprot.2014.04.01724768905
   PubMed Web of Science ®Google Scholar
• Zhang K, Zheng S, Yang JS, Chen Y, Cheng Z. Comprehensive profiling of protein lysine acetylation in Escherichia coli. J Proteome Res. 2013;12(2):844–851. doi:10.1021/pr300912q23294111
   PubMed Web of Science ®Google Scholar
• Kim D, Yu BJ, Kim JA, et al. The acetylproteome of Gram positive model bacterium Bacillus subtilis. Proteomics. 2013;13(10–11):1726–1736. doi:10.1002/pmic.20120000123468065
   PubMed Web of Science ®Google Scholar
• Rardin MJ, Held JM, Gibson BW. Targeted quantitation of acetylated lysine peptides by selected reaction monitoring mass spectrometry Methods Mol Biol. 2013;1077:121–131.24014403
   PubMedGoogle Scholar
• Manteca A, Ye J, Sánchez J, Jensen ON. Phosphoproteome analysis of Streptomyces development reveals extensive protein phosphorylation accompanying bacterial differentiation. J Proteome Res. 2011;10(12):5481–5492. doi:10.1021/pr200762y21999169
   PubMed Web of Science ®Google Scholar
• Ouidir T, Cosette P, Jouenne T, Hardouin J. Proteomic profiling of lysine acetylation in Pseudomonas aeruginosa reveals the diversity of acetylated proteins. Proteomics. 2015;15(13):2152–2157. doi:10.1002/pmic.20150005625900529
   PubMed Web of Science ®Google Scholar
• Sun F, Ding Y, Ji Q, et al. Protein cysteine phosphorylation of SarA/MgrA family transcriptional regulators mediates bacterial virulence and antibiotic resistance. Proc Natl Acad Sci. 2012;109(38):15461–15466. doi:10.1073/pnas.120595210922927394
   PubMed Web of Science ®Google Scholar
• Liu F, Yang M, Wang X, et al. Acetylome analysis reveals diverse functions of lysine acetylation in Mycobacterium tuberculosis. Mol Cell Proteomics. 2014;13(12):3352–3366. doi:10.1074/mcp.M114.04196225180227
   PubMed Web of Science ®Google Scholar
• Leach MD, Brown AJ. Posttranslational modifications of proteins in the pathobiology of medically relevant fungi. Eukaryot Cell. 2012;11(2):98–108. doi:10.1128/EC.05238-1122158711
   PubMedGoogle Scholar
• Croken MM, Nardelli SC, Kim K. Chromatin modifications, epigenetics, and how protozoan parasites regulate their lives. Trends Parasitol. 2012;28(5):202–213. doi:10.1016/j.pt.2012.02.00922480826
   PubMed Web of Science ®Google Scholar
• Bagdonaite I, Nordén R, Joshi HJ, et al. Global mapping of O-glycosylation of varicella zoster virus, human cytomegalovirus, and Epstein-Barr virus. J Biol Chem. 2016;291(23):12014–12028. doi:10.1074/jbc.M116.72174627129252
   PubMed Web of Science ®Google Scholar
• Kulej K, Avgousti DC, Weitzman MD, Garcia BA. Characterization of histone post-translational modifications during virus infection using mass spectrometry-based proteomics. Methods. 2015;90:8–20. doi:10.1016/j.ymeth.2015.06.00826093074
   PubMed Web of Science ®Google Scholar
• Zielinska DF, Gnad F, Schropp K, Wiśniewski JR, Mann M. Mapping N-glycosylation sites across seven evolutionarily distant species reveals a divergent substrate proteome despite a common core machinery. Mol Cell. 2012;46(4):542–548. doi:10.1016/j.molcel.2012.04.03122633491
   PubMed Web of Science ®Google Scholar
• Udeshi ND, Svinkina T, Mertins P, et al. Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000 s of ubiquitination sites in single proteomics experiments. Mol Cell Proteomics. 2013;12(3):825–831. doi:10.1074/mcp.O112.02709423266961
   PubMed Web of Science ®Google Scholar
• Hendriks IA, D’souza RC, Yang B, Verlaan-de Vries M, Mann M, Vertegaal AC. Uncovering global SUMOylation signaling networks in a site-specific manner. Nat Struct Mol Biol. 2014;21(10):927. doi:10.1038/nsmb.289025218447
   PubMed Web of Science ®Google Scholar
• Kusebauch U, Campbell DS, Deutsch EW, et al. Human SRMAtlas: a resource of targeted assays to quantify the complete human proteome. Cell. 2016;166(3):766–778. doi:10.1016/j.cell.2016.06.04127453469
   PubMed Web of Science ®Google Scholar
• Champasa K, Longwell SA, Eldridge AM, Stemmler EA, Dube DH. Targeted identification of glycosylated proteins in the gastric pathogen Helicobacter pylori (Hp). Mol Cell Proteomics. 2013;12(9):2568–2586. doi:10.1074/mcp.M113.02956123754784
   PubMed Web of Science ®Google Scholar
• Engholm-Keller K, Larsen MR. Improving the phosphoproteome coverage for limited sample amounts using TiO2-SIMAC-HILIC (TiSH) phosphopeptide enrichment and fractionation Methods Mol Biol. 2016;1355:161–177.26584925
   PubMedGoogle Scholar
• Nesvizhskii AI. Proteogenomics: concepts, applications and computational strategies. Nat Methods. 2014;11(11):1114. doi:10.1038/nmeth.314425357241
   PubMed Web of Science ®Google Scholar
• Abd-Alla AM, Kariithi HM, Cousserans F, et al. Comprehensive annotation of Glossina pallidipes salivary gland hypertrophy virus from Ethiopian tsetse flies: a proteogenomics approach. J Gen Virol. 2016;97(4):1010. doi:10.1099/jgv.0.00040926801744
   PubMed Web of Science ®Google Scholar
• Miranda-CasoLuengo AA, Staunton PM, Dinan AM, Lohan AJ, Loftus BJ. Functional characterization of the Mycobacterium abscessus genome coupled with condition specific transcriptomics reveals conserved molecular strategies for host adaptation and persistence. BMC Genomics. 2016;17(1):553. doi:10.1186/s12864-016-2868-y27495169
   PubMed Web of Science ®Google Scholar
• Fan J, Saha S, Barker G, et al. Galaxy integrated omics: web-based standards-compliant workflows for proteomics informed by transcriptomics. Mol Cell Proteomics. 2015;14(11):3087–3093. doi:10.1074/mcp.O115.04877726269333
   PubMed Web of Science ®Google Scholar
• Khatri K, Klein JA, White MR, et al. Integrated omics and computational glycobiology reveal structural basis for influenza A virus glycan microheterogeneity and host interactions. Mol Cell Proteomics. 2016;15(6):1895–1912. doi:10.1074/mcp.M116.05801626984886
   PubMed Web of Science ®Google Scholar
• Chen W-H, van Noort V, Lluch-Senar M, et al. Integration of multi-omics data of a genome-reduced bacterium: prevalence of post-transcriptional regulation and its correlation with protein abundances. Nucleic Acids Res. 2016;44(3):1192–1202. doi:10.1093/nar/gkw00426773059
   PubMed Web of Science ®Google Scholar
• Gorenshteyn D, Zaslavsky E, Fribourg M, et al. Interactive big data resource to elucidate human immune pathways and diseases. Immunity. 2015;43(3):605–614. doi:10.1016/j.immuni.2015.08.01426362267
   PubMed Web of Science ®Google Scholar
• Kühner S, van Noort V, Betts MJ, et al. Proteome organization in a genome-reduced bacterium. Science. 2009;326(5957):1235–1240. doi:10.1126/science.117634319965468
   PubMed Web of Science ®Google Scholar
• Mirrashidi KM, Elwell CA, Verschueren E, et al. Global mapping of the Inc-human interactome reveals that retromer restricts Chlamydia infection. Cell Host Microbe. 2015;18(1):109–121. doi:10.1016/j.chom.2015.06.00426118995
   PubMed Web of Science ®Google Scholar
• Miersch S, LaBaer J. Nucleic acid programmable protein arrays: versatile tools for array‐based functional protein studies. Curr Protoc Protein Sci. 2011;64(1):27.22.21–27.22. 26.
   Google Scholar
• Gagarinova A, Phanse S, Cygler M, Babu M. Insights from protein-protein interaction studies on bacterial pathogenesis. Expert Rev Proteomics. 2017;14(9):779–797. doi:10.1080/14789450.2017.136560328786313
   PubMed Web of Science ®Google Scholar
• Vranakis I, Goniotakis I, Psaroulaki A, et al. Proteome studies of bacterial antibiotic resistance mechanisms. J Proteomics. 2014;97:88–99. doi:10.1016/j.jprot.2013.10.02724184230
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098. doi:10.1016/S1473-3099(13)70318-924252483
   PubMed Web of Science ®Google Scholar
• Chen B, Zhang D, Wang X, et al. Proteomics progresses in microbial physiology and clinical antimicrobial therapy. Eur J Clin Microbiol Infect Dis. 2017;36(3):403–413. doi:10.1007/s10096-016-2816-427812806
   PubMed Web of Science ®Google Scholar
• Karlsson C, Malmström L, Aebersold R, Malmström J. Proteome-wide selected reaction monitoring assays for the human pathogen Streptococcus pyogenes. Nat Commun. 2012;3:1301. doi:10.1038/ncomms229723250431
   PubMed Web of Science ®Google Scholar
• Schneider T, Riedel K. Environmental proteomics: analysis of structure and function of microbial communities. Proteomics. 2010;10(4):785–798. doi:10.1002/pmic.20090045019953545
   PubMed Web of Science ®Google Scholar
• Bush K, Bradford PA. β-Lactams and β-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med. 2016;6(8):a025247. doi:10.1101/cshperspect.a02524727329032
   PubMed Web of Science ®Google Scholar
• Dam S, Pagès J-M, Masi M. Stress responses, outer membrane permeability control and antimicrobial resistance in Enterobacteriaceae 2 3. Microbiology. 2018;164(3):260–267. doi:10.1099/mic.0.00061329458656
   PubMed Web of Science ®Google Scholar
• Saleh S, Staes A, Deborggraeve S, Gevaert K. Targeted proteomics for studying pathogenic bacteria. Proteomics. 2019;19(16):1800435. doi:10.1002/pmic.201800435
   Web of Science ®Google Scholar
• Kapoor G, Saigal S, Elongavan A. Action and resistance mechanisms of antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol. 2017;33(3):300. doi:10.4103/joacp.JOACP_349_1529109626
   PubMedGoogle Scholar
• Blair JM, Bavro VN, Ricci V, et al. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity. Proc Natl Acad Sci. 2015;112(11):3511–3516. doi:10.1073/pnas.141993911225737552
   PubMed Web of Science ®Google Scholar
• Pérez-Llarena FJ, Bou G. Proteomics as a tool for studying bacterial virulence and antimicrobial resistance. Front Microbiol. 2016;7:410. doi:10.3389/fmicb.2016.0041027065974
   PubMed Web of Science ®Google Scholar
• Vala MH, Hallajzadeh M, Hashemi A, et al. Detection of Ambler class A, B and D ß-lactamases among Pseudomonas aeruginosa and Acinetobacter baumannii clinical isolates from burn patients. Ann Burns Fire Disasters. 2014;27(1):8.25249841
   PubMedGoogle Scholar
• Park AJ, Surette MD, Khursigara CM. Antimicrobial targets localize to the extracellular vesicle-associated proteome of Pseudomonas aeruginosa grown in a biofilm. Front Microbiol. 2014;5:464. doi:10.3389/fmicb.2014.0046425232353
   PubMed Web of Science ®Google Scholar
• Dos Santos KV, Diniz CG, de Castro Veloso L, et al. Proteomic analysis of Escherichia coli with experimentally induced resistance to piperacillin/tazobactam. Res Microbiol. 2010;161(4):268–275. doi:10.1016/j.resmic.2010.03.00620381611
   PubMed Web of Science ®Google Scholar
• Chaussee MA, McDowell EJ, Rieck LD, Callegari EA, Chaussee MS. Proteomic analysis of a penicillin-tolerant rgg mutant strain of Streptococcus pyogenes. J Antimicrob Chemother. 2006;58(4):752–759. doi:10.1093/jac/dkl31916891633
   PubMed Web of Science ®Google Scholar
• Monteiro R, Vitorino R, Domingues P, et al. Proteome of a methicillin-resistant Staphylococcus aureus clinical strain of sequence type ST398. J Proteomics. 2012;75(10):2892–2915. doi:10.1016/j.jprot.2011.12.03622245554
   PubMed Web of Science ®Google Scholar
• Solis N, Parker BL, Kwong SM, Robinson G, Firth N, Cordwell SJ. Staphylococcus aureus surface proteins involved in adaptation to oxacillin identified using a novel cell shaving approach. J Proteome Res. 2014;13(6):2954–2972. doi:10.1021/pr500107p24708102
   PubMed Web of Science ®Google Scholar
• Tiwari V, Tiwari M. Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii. Front Microbiol. 2014;5:512. doi:10.3389/fmicb.2014.0051225309531
   PubMed Web of Science ®Google Scholar
• Lebreton F, Cattoir V. Resistance to Glycopeptide Antibiotics In: Bonev BB, Brown NM, editors. Bacterial Resistance to Antibiotics: From Molecules to Man. 2019:8051.
   Google Scholar
• Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014;12(10):1221–1236. doi:10.1586/14787210.2014.95609225199988
   PubMed Web of Science ®Google Scholar
• Lima TB, Pinto MFS, Ribeiro SM, et al. Bacterial resistance mechanism: what proteomics can elucidate. FASEB J. 2013;27(4):1291–1303. doi:10.1096/fj.12-22112723349550
   PubMed Web of Science ®Google Scholar
• Wang X, He X, Jiang Z, et al. Proteomic analysis of the Enterococcus faecalis V583 strain and clinical isolate V309 under vancomycin treatment. J Proteome Res. 2010;9(4):1772–1785. doi:10.1021/pr901216e20128627
   PubMed Web of Science ®Google Scholar
• Ramos S, Chafsey I, Silva N, et al. Effect of vancomycin on the proteome of the multiresistant Enterococcus faecium SU18 strain. J Proteomics. 2015;113:378–387. doi:10.1016/j.jprot.2014.10.01225449832
   PubMed Web of Science ®Google Scholar
• Chen H, Liu Y, Zhao C, et al. Comparative proteomics-based identification of genes associated with glycopeptide resistance in clinically derived heterogeneous vancomycin-intermediate Staphylococcus aureus strains. PLoS One. 2013;8(6):e66880. doi:10.1371/journal.pone.006688023840544
   PubMed Web of Science ®Google Scholar
• Dabul ANG, Kos VN, Gilmore MS, Camargo IL. Draft genome sequence of methicillin-resistant Staphylococcus aureus strain SA16, representative of an endemic clone from a Brazilian hospital. Genome Announc. 2013;1(5):e00754–00713. doi:10.1128/genomeA.00754-1324051324
   PubMedGoogle Scholar
• Müller A, Grein F, Otto A, et al. Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. Int J Med Microbiol. 2018;308(3):335–348. doi:10.1016/j.ijmm.2017.12.00229429584
   PubMed Web of Science ®Google Scholar
• Yu R, Dale SE, Yamamura D, Stankus V, Lee C. Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis. Can J Infect Dis Med Microbiol. 2012;23(2):e48–e50. doi:10.1155/2012/13847023730321
   PubMed Web of Science ®Google Scholar
• Fischer A, Yang S-J, Bayer AS, et al. Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach. J Antimicrob Chemother. 2011;66(8):1696–1711. doi:10.1093/jac/dkr19521622973
   PubMed Web of Science ®Google Scholar
• Wecke T, Zühlke D, Mäder U, et al. Daptomycin versus friulimicin B: in-depth profiling of Bacillus subtilis cell envelope stress responses. Antimicrob Agents Chemother. 2009;53(4):1619–1623. doi:10.1128/AAC.01046-0819164157
   PubMed Web of Science ®Google Scholar
• Reyes J, Panesso D, Tran TT, et al. A liaR deletion restores susceptibility to daptomycin and antimicrobial peptides in multidrug-resistant Enterococcus faecalis. J Infect Dis. 2015;211(8):1317–1325. doi:10.1093/infdis/jiu60225362197
   PubMed Web of Science ®Google Scholar
• Yahav D, Farbman L, Leibovici L, Paul M. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect. 2012;18(1):18–29. doi:10.1111/j.1469-0691.2011.03734.x22168320
   PubMed Web of Science ®Google Scholar
• Blair JM, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJ. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol. 2015;13(1):42. doi:10.1038/nrmicro338025435309
   PubMed Web of Science ®Google Scholar
• Aghapour Z, Gholizadeh P, Ganbarov K, et al. Molecular mechanisms related to colistin resistance in Enterobacteriaceae. Infect Drug Resist. 2019;12:965. doi:10.2147/IDR.S19984431190901
   PubMed Web of Science ®Google Scholar
• Li H, Wang Y, Meng Q, et al. Comprehensive proteomic and metabolomic profiling of mcr-1-mediated colistin resistance in Escherichia coli. Int J Antimicrob Agents. 2019;53(6):795–804. doi:10.1016/j.ijantimicag.2019.02.01430811973
   PubMed Web of Science ®Google Scholar
• Chua SL, Tan S-Y-Y, Rybtke MT, et al. Bis-(3′-5′)-cyclic dimeric GMP regulates antimicrobial peptide resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2013;57(5):2066–2075. doi:10.1128/AAC.02499-1223403434
   PubMed Web of Science ®Google Scholar
• da Cunha NB, Cobacho NB, Viana JF, et al. The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts. Drug Discov Today. 2017;22(2):234–248. doi:10.1016/j.drudis.2016.10.01727890668
   PubMed Web of Science ®Google Scholar
• Chiu Y, Kuo TY, Lin CC, Chen WJ. Proteomic analysis reveals responsive proteins of Vibrio parahaemolyticus on exposure to cationic antimicrobial peptides. J Appl Microbiol. 2011;110(1):80–89. doi:10.1111/j.1365-2672.2010.04856.x20880213
   PubMed Web of Science ®Google Scholar
• Chowdhury MH, Diamond G, Ryan LK. 11 Synergy of Antimicrobial Peptides In: Wang G, editor. Antimicrobial Peptides: Discovery, Design and Novel Therapeutic Strategies. 2017 Vol. 188.
   Google Scholar
• Chernov VM, Chernova OA, Mouzykantov AA, et al. Antimicrobial resistance in mollicutes: known and newly emerging mechanisms. FEMS Microbiol Lett. 2018;365(18):fny185. doi:10.1093/femsle/fny185
   Web of Science ®Google Scholar
• Shen CJ, Kuo TY, Lin CC, Chow LP, Chen WJ. Proteomic identification of membrane proteins regulating antimicrobial peptide resistance in Vibrio parahaemolyticus. J Appl Microbiol. 2010;108(4):1398–1407. doi:10.1111/j.1365-2672.2009.04544.x19796120
   PubMed Web of Science ®Google Scholar
• Maria-Neto S, de Souza Cândido E, Rodrigues DR, et al. Deciphering the magainin resistance process of Escherichia coli strains in light of the cytosolic proteome. Antimicrob Agents Chemother. 2012;56(4):1714–1724. doi:10.1128/AAC.05558-1122290970
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596. doi:10.1128/CMR.00064-1628275006
   PubMed Web of Science ®Google Scholar
• Jeannot K, Bolard A, Plesiat P. Resistance to polymyxins in Gram-negative organisms. Int J Antimicrob Agents. 2017;49(5):526–535. doi:10.1016/j.ijantimicag.2016.11.02928163137
   PubMed Web of Science ®Google Scholar
• De Majumdar S, Yu J, Fookes M, et al. Elucidation of the RamA regulon in Klebsiella pneumoniae reveals a role in LPS regulation. PLoS Pathog. 2015;11(1):e1004627. doi:10.1371/journal.ppat.100462725633080
   PubMed Web of Science ®Google Scholar
• Zhang YF, Han K, Chandler CE, Tjaden B, Ernst RK, Lory S. Probing the sRNA regulatory landscape of P. aeruginosa: post transcriptional control of determinants of pathogenicity and antibiotic susceptibility. Mol Microbiol. 2017;106(6):919–937. doi:10.1111/mmi.1385728976035
   PubMed Web of Science ®Google Scholar
• Dinos G, Athanassopoulos C, Missiri D, et al. Chloramphenicol derivatives as antibacterial and anticancer agents: historic problems and current solutions. Antibiotics. 2016;5(2):20. doi:10.3390/antibiotics5020020
   Web of Science ®Google Scholar
• Roberts MC, Schwarz S. Tetracycline and chloramphenicol resistance mechanisms In: Mayers DL, Sobel JD, Ouellette M, Kaye KS, Marchaim, D, editors. Antimicrobial Drug Resistance. Springer; 2017:231–243.
   Google Scholar
• Li H, Lin X-M, Wang S-Y, Peng X-X. Identification and antibody-therapeutic targeting of chloramphenicol-resistant outer membrane proteins in Escherichia coli. J Proteome Res. 2007;6(9):3628–3636. doi:10.1021/pr070307y17711325
   PubMed Web of Science ®Google Scholar
• Zhang QS, Ye C, Yang X. Anti-outer membrane vesicle antibodies increase antibiotic sensitivity of pan-drug-resistant Acinetobacter baumannii. Front Microbiol. 2019;10:1379. doi:10.3389/fmicb.2019.0137931275290
   PubMed Web of Science ®Google Scholar
• Biot FV, Valade E, Garnotel E, et al. Involvement of the efflux pumps in chloramphenicol selected strains of Burkholderia thailandensis: proteomic and mechanistic evidence. PLoS One. 2011;6(2):e16892. doi:10.1371/journal.pone.001689221347382
   PubMed Web of Science ®Google Scholar
• Peng B, Wang C, Li H, et al. Outer membrane proteins form specific patterns in antibiotic-resistant Edwardsiella tarda. Front Microbiol. 2017;8:69. doi:10.3389/fmicb.2017.0006928210241
   PubMed Web of Science ®Google Scholar
• Long KS, Vester B. Resistance to linezolid caused by modifications at its binding site on the ribosome. Antimicrob Agents Chemother. 2012;56(2):603–612. doi:10.1128/AAC.05702-1122143525
   PubMed Web of Science ®Google Scholar
• Voigt B, Albrecht D, Dalhoff A. Mode of action of MCB3681 in Staphylococcus aureus–a proteomic study. Arch Clin Microbiol. 2016;7(6). doi:10.4172/1989-8436.100061
   Google Scholar
• Feng J, Billal DS, Lupien A, et al. Proteomic and transcriptomic analysis of linezolid resistance in Streptococcus pneumoniae. J Proteome Res. 2011;10(10):4439–4452. doi:10.1021/pr200221s21875071
   PubMed Web of Science ®Google Scholar
• Grossman TH. Tetracycline antibiotics and resistance. Cold Spring Harb Perspect Med. 2016;6(4):a025387. doi:10.1101/cshperspect.a02538726989065
   PubMed Web of Science ®Google Scholar
• Falagas ME, Vardakas KZ, Kapaskelis A, Triarides NA, Roussos NS. Tetracyclines for multidrug-resistant Acinetobacter baumannii infections. Int J Antimicrob Agents. 2015;45(5):455–460. doi:10.1016/j.ijantimicag.2014.12.03125801348
   PubMed Web of Science ®Google Scholar
• Yun SH, Park EC, Lee S-Y, et al. Antibiotic treatment modulates protein components of cytotoxic outer membrane vesicles of multidrug-resistant clinical strain, Acinetobacter baumannii DU202. Clin Proteomics. 2018;15(1):28. doi:10.1186/s12014-018-9204-230186054
   PubMed Web of Science ®Google Scholar
• Lin X, Kang L, Li H, Peng X. Fluctuation of multiple metabolic pathways is required for Escherichia coli in response to chlortetracycline stress. Mol Biosyst. 2014;10(4):901–908. doi:10.1039/C3MB70522F24510206
   PubMedGoogle Scholar
• Kudo F, Eguchi T. Aminoglycoside antibiotics: new insights into the biosynthetic machinery of old drugs. Chem Rec. 2016;16(1):4–18. doi:10.1002/tcr.20150021026455715
   PubMed Web of Science ®Google Scholar
• Jackson J, Chen C, Buising K. Aminoglycosides: how should we use them in the 21st century? Curr Opin Infect Dis. 2013;26(6):516–525. doi:10.1097/QCO.000000000000001224141453
   PubMed Web of Science ®Google Scholar
• Ma Y, Guo C, Li H, Peng X-X. Low abundance of respiratory nitrate reductase is essential for Escherichia coli in resistance to aminoglycoside and cephalosporin. J Proteomics. 2013;87:78–88. doi:10.1016/j.jprot.2013.05.01923711407
   PubMed Web of Science ®Google Scholar
• Nabu S, Lawung R, Isarankura-Na-Ayudhya P, Isarankura-Na-Ayudhya C, Roytrakul S, Prachayasittikul V. Reference map and comparative proteomic analysis of Neisseria gonorrhoeae displaying high resistance against spectinomycin. J Med Microbiol. 2014;63(3):371–385. doi:10.1099/jmm.0.067595-024567501
   PubMed Web of Science ®Google Scholar
• Al-Majdoub ZM, Owoseni A, Gaskell SJ, Barber J. Effects of gentamicin on the proteomes of aerobic and oxygen-limited Escherichia coli. J Med Chem. 2013;56(7):2904–2910. doi:10.1021/jm301858u23517076
   PubMed Web of Science ®Google Scholar
• Zhang D-F, Li H, Lin X-M, Peng X-X. Outer membrane proteomics of kanamycin-resistant Escherichia coli identified MipA as a novel antibiotic resistance-related protein. FEMS Microbiol Lett. 2015;362(11). doi:10.1093/femsle/fnv074
   Web of Science ®Google Scholar
• Hu Y, Zhang M, Lu B, Dai J. Helicobacter pylori and antibiotic resistance, a continuing and intractable problem. Helicobacter. 2016;21(5):349–363. doi:10.1111/hel.1229926822340
   PubMed Web of Science ®Google Scholar
• Wilson DN. Ribosome-targeting antibiotics and mechanisms of bacterial resistance. Nat Rev Microbiol. 2014;12(1):35. doi:10.1038/nrmicro315524336183
   PubMed Web of Science ®Google Scholar
• Cornick J, Bentley S. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. Microbes Infect. 2012;14(7–8):573–583. doi:10.1016/j.micinf.2012.01.01222342898
   PubMed Web of Science ®Google Scholar
• Cash P, Argo E, Ford L, Lawrie L, McKenzie H. A proteomic analysis of erythromycin resistance in Streptococcus pneumoniae. Electrophoresis. 1999;20(11):2259–2268. doi:10.1002/(SICI)1522-2683(19990801)20:11<2259::AID-ELPS2259>3.0.CO;2-F10493130
   PubMed Web of Science ®Google Scholar
• Smiley R, Bailey J, Sethuraman M, Posecion N, Ali MS. Comparative proteomics analysis of sarcosine insoluble outer membrane proteins from clarithromycin resistant and sensitive strains of Helicobacter pylori. J Microbiol. 2013;51(5):612–618. doi:10.1007/s12275-013-3029-524173641
   PubMed Web of Science ®Google Scholar
• Redgrave LS, Sutton SB, Webber MA, Piddock LJ. Fluoroquinolone resistance: mechanisms, impact on bacteria, and role in evolutionary success. Trends Microbiol. 2014;22(8):438–445. doi:10.1016/j.tim.2014.04.00724842194
   PubMed Web of Science ®Google Scholar
• Hooper DC, Jacoby GA. Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance. Cold Spring Harb Perspect Med. 2016;6(9):a025320. doi:10.1101/cshperspect.a02532027449972
   PubMed Web of Science ®Google Scholar
• Drlica K, Zhao X, Malik M, Hiasa H, Mustaev A, Kerns R. Fluoroquinolone Resistance In: Bonev BB, Brown NM,editors. Bacterial Resistance to Antibiotics: From Molecules to Man. 2019:8125.
   Google Scholar
• Coldham NG, Randall LP, Piddock LJ, Woodward MJ. Effect of fluoroquinolone exposure on the proteome of Salmonella enterica serovar Typhimurium. J Antimicrob Chemother. 2006;58(6):1145–1153. doi:10.1093/jac/dkl41317062612
   PubMed Web of Science ®Google Scholar
• Vranakis I, De Bock P-J, Papadioti A, et al. Identification of potentially involved proteins in levofloxacin resistance mechanisms in Coxiella burnetii. J Proteome Res. 2011;10(2):756–762. doi:10.1021/pr100906v21070068
   PubMed Web of Science ®Google Scholar
• Lin X-M, Li H, Wang C, Peng X-X. Proteomic analysis of nalidixic acid resistance in Escherichia coli: identification and functional characterization of OM proteins. J Proteome Res. 2008;7(6):2399–2405. doi:10.1021/pr800073c18438992
   PubMed Web of Science ®Google Scholar
• Reeves PT. Antibiotics: groups and properties In: Wang J, MacNeil JD, Kay JF, editors. Chemical Analysis of Antibiotic Residues in Food. New Jersey (USA): Wiley Publishing; 2012:30–31.
   Google Scholar
• Huang C-H, Chuang M-H, Lo W-L, et al. Alkylhydroperoxide reductase of Helicobacter pylori as a biomarker for gastric patients with different pathological manifestations. Biochimie. 2011;93(7):1115–1123. doi:10.1016/j.biochi.2011.03.00821440595
   PubMed Web of Science ®Google Scholar
• Isidro J, Mendes AL, Serrano M, Henriques AO, Oleastro M. Overview of clostridium difficile infection: life cycle, epidemiology, antimicrobial resistance and treatment In: Clostridium Difficile-A Comprehensive Overview. IntechOpen; 2017.
   Google Scholar
• Chong PM, Lynch T, McCorrister S, et al. Proteomic analysis of a NAP1 Clostridium difficile clinical isolate resistant to metronidazole. PLoS One. 2014;9(1):e82622. doi:10.1371/journal.pone.008262224400070
   PubMed Web of Science ®Google Scholar
• Goldstein BP. Resistance to rifampicin: a review. J Antibiot. 2014;67(9):625. doi:10.1038/ja.2014.10725118103
   PubMed Web of Science ®Google Scholar
• Cai X-C, Xi H, Liang L, et al. Rifampicin-resistance mutations in the rpoB gene in Bacillus velezensis CC09 have pleiotropic effects. Front Microbiol. 2017;8:178. doi:10.3389/fmicb.2017.0017828243227
   PubMed Web of Science ®Google Scholar
• Fajardo-Cavazos P, Leehan JD, Nicholson WL. Alterations in the spectrum of spontaneous rifampicin-resistance mutations in the Bacillus subtilis rpoB gene after cultivation in the human spaceflight environment. Front Microbiol. 2018;9:192. doi:10.3389/fmicb.2018.0019229491852
   PubMed Web of Science ®Google Scholar
• Neri A, Mignogna G, Fazio C, Giorgi A, Schininà ME, Stefanelli P. Neisseria meningitidis rifampicin resistant strains: analysis of protein differentially expressed. BMC Microbiol. 2010;10(1):246. doi:10.1186/1471-2180-10-24620868485
   PubMed Web of Science ®Google Scholar
• Sandalakis V, Psaroulaki A, De Bock P-J, et al. Investigation of rifampicin resistance mechanisms in Brucella abortus using MS-driven comparative proteomics. J Proteome Res. 2012;11(4):2374–2385. doi:10.1021/pr201122w22360387
   PubMed Web of Science ®Google Scholar
• Johansen TB, Scheffer L, Jensen VK, Bohlin J, Feruglio SL. Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective. Sci Rep. 2018;8(1):8538. doi:10.1038/s41598-018-26906-329867163
   PubMed Web of Science ®Google Scholar
• Provenzano JC, JF S, Rôças IN, Domingues RR, Leme AFP, Silva MR. Metaproteome analysis of endodontic infections in association with different clinical conditions. PLoS One. 2013;8(10):e76108. doi:10.1371/journal.pone.007610824143178
   PubMed Web of Science ®Google Scholar
• Wang Y, Huang K-Y, Huo Y. Proteomic comparison between Salmonella Typhimurium and Salmonella Typhi. J Microbiol. 2014;52(1):71–76. doi:10.1007/s12275-014-3204-324390840
   PubMed Web of Science ®Google Scholar